Trial Profile
A Multi-center, Randomized, Double-blind, Controlled Dose-finding Study to Evaluate the Safety and Efficacy of MP4OX Treatment Plus Standard of Care in Severely Injured Trauma Patients With Lactic Acidosis Due to Hemorrhagic Shock
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Oct 2014
Price :
$35
*
At a glance
- Drugs Human haemoglobin (Primary)
- Indications Lactic acidosis
- Focus Therapeutic Use
- Sponsors Sangart
- 10 Oct 2014 New trial record